The Maxwell Finland Lecture 2025: Antimicrobial Resistance At The Bedside: Translating Science Into Patient Outcomes

Clicks: 1
ID: 315011
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #399 of 431 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 431 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Antimicrobial resistance (AMR) is one of the most pressing public health threats of the 21st century. The development of resistance to antimicrobial agents is multifactorial. However, a major driver of AMR is the remarkable capacity of microorganisms to rapidly evolve, continually challenging the practice of infectious diseases and undermining the effectiveness of miracle drugs we call antibiotics. Dr. Maxwell Finland was a pioneer in this field, uniquely positioned to witness-and help shape-the transition from an era without antimicrobials to one transformed by life-saving therapies that revolutionized medicine. As AMR continues to rise and antibiotics cease to be effective, Dr. Finland's legacy is more relevant than ever.
Reference Key
openalex_W7162462037 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cesar A Arias
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag273
URL
https://doi.org/10.1093/infdis/jiag273
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.